Clinical Trial Update: Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial of cytokine-induced memory-like NK cell adoptive therapy after haploidentical donor stem cell transplantation for acute myeloid leukemia is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cytokine-induced memory-like NK cell therapy (Cytokine-induced memory-like NK cells)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING